These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12668405)

  • 1. Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up.
    Durham RC; Guthrie M; Morton RV; Reid DA; Treliving LR; Fowler D; Macdonald RR
    Br J Psychiatry; 2003 Apr; 182():303-11. PubMed ID: 12668405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial.
    Tarrier N; Lewis S; Haddock G; Bentall R; Drake R; Kinderman P; Kingdon D; Siddle R; Everitt J; Leadley K; Benn A; Grazebrook K; Haley C; Akhtar S; Davies L; Palmer S; Dunn G
    Br J Psychiatry; 2004 Mar; 184():231-9. PubMed ID: 14990521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis.
    Freeman D; Dunn G; Startup H; Pugh K; Cordwell J; Mander H; Černis E; Wingham G; Shirvell K; Kingdon D
    Lancet Psychiatry; 2015 Apr; 2(4):305-13. PubMed ID: 26360083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive behaviour therapy for psychotic symptoms: a randomized controlled effectiveness trial.
    Kråkvik B; Gråwe RW; Hagen R; Stiles TC
    Behav Cogn Psychother; 2013 Oct; 41(5):511-24. PubMed ID: 23635846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive-behavioral therapy in schizophrenia.
    Kumari V; Peters ER; Fannon D; Antonova E; Premkumar P; Anilkumar AP; Williams SC; Kuipers E
    Biol Psychiatry; 2009 Sep; 66(6):594-602. PubMed ID: 19560121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual-reality-based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic disorders: a single-blind randomised controlled trial.
    Pot-Kolder RMCA; Geraets CNW; Veling W; van Beilen M; Staring ABP; Gijsman HJ; Delespaul PAEG; van der Gaag M
    Lancet Psychiatry; 2018 Mar; 5(3):217-226. PubMed ID: 29429948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase.
    Kuipers E; Garety P; Fowler D; Dunn G; Bebbington P; Freeman D; Hadley C
    Br J Psychiatry; 1997 Oct; 171():319-27. PubMed ID: 9373419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. London-east Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. III: Follow-up and economic evaluation at 18 months.
    Kuipers E; Fowler D; Garety P; Chisholm D; Freeman D; Dunn G; Bebbington P; Hadley C
    Br J Psychiatry; 1998 Jul; 173():61-8. PubMed ID: 9850205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavior therapy in early psychosis with a focus on depression and low self-esteem: A randomized controlled trial.
    Sönmez N; Romm KL; Østefjells T; Grande M; Jensen LH; Hummelen B; Tesli M; Melle I; Røssberg JI
    Compr Psychiatry; 2020 Feb; 97():152157. PubMed ID: 31935529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-behavioural therapy for persistent and recurrent psychosis in people with schizophrenia-spectrum disorder: cost-effectiveness analysis.
    van der Gaag M; Stant AD; Wolters KJ; Buskens E; Wiersma D
    Br J Psychiatry; 2011 Jan; 198(1):59-65, sup 1. PubMed ID: 21200078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcome in brief cognitive behavior therapy for schizophrenia.
    Brabban A; Tai S; Turkington D
    Schizophr Bull; 2009 Sep; 35(5):859-64. PubMed ID: 19571248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive Behavioural Therapy for Nightmares for Patients with Persecutory Delusions (Nites): An Assessor-Blind, Pilot Randomized Controlled Trial.
    Sheaves B; Holmes EA; Rek S; Taylor KM; Nickless A; Waite F; Germain A; Espie CA; Harrison PJ; Foster R; Freeman D
    Can J Psychiatry; 2019 Oct; 64(10):686-696. PubMed ID: 31129983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group cognitive behavioural therapy for Chinese patients with psychotic disorder: A feasibility controlled study.
    Wong AWS; Ting KT; Chen EYH
    Asian J Psychiatr; 2019 Jan; 39():157-164. PubMed ID: 30639991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study.
    Favrod J; Rexhaj S; Bardy S; Ferrari P; Hayoz C; Moritz S; Conus P; Bonsack C
    Eur Psychiatry; 2014 Jun; 29(5):275-81. PubMed ID: 24176646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive behavioural therapy for drug-resistant psychosis.
    Garety PA; Kuipers L; Fowler D; Chamberlain F; Dunn G
    Br J Med Psychol; 1994 Sep; 67 ( Pt 3)():259-71. PubMed ID: 7803318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief cognitive-behavioural therapy for patients in the community with schizophrenia: randomised controlled trial in Beijing, China.
    Guo ZH; Li ZJ; Ma Y; Sun J; Guo JH; Li WX; Wang ZQ; Xu HL; Ng RM; Turkington D; Kingdon D
    Br J Psychiatry; 2017 Mar; 210(3):223-229. PubMed ID: 28069563
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the Effectiveness of Two Cognitive-Behavioral Group Therapy Programs for Schizophrenia: Results of a Short-Term Randomized Control Trial.
    Mortan Sevi O; Tekinsav Sutcu S; Yesilyurt S; Turan Eroglu S; Gunes B
    Community Ment Health J; 2020 Feb; 56(2):222-228. PubMed ID: 31468249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot randomised controlled trial of culturally adapted cognitive behavior therapy for psychosis (CaCBTp) in Pakistan.
    Husain MO; Chaudhry IB; Mehmood N; Rehman RU; Kazmi A; Hamirani M; Kiran T; Bukhsh A; Bassett P; Husain MI; Naeem F; Husain N
    BMC Health Serv Res; 2017 Dec; 17(1):808. PubMed ID: 29207980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durability of the effects of cognitive-behavioural therapy in the treatment of chronic schizophrenia: 12-month follow-up.
    Tarrier N; Wittkowski A; Kinney C; McCarthy E; Morris J; Humphreys L
    Br J Psychiatry; 1999 Jun; 174():500-4. PubMed ID: 10616627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.